Institutional Sign In

Go

Pfizer Czech Republic - Net Debt Growth

Pfizer CR`s Net Debt Growth reached -5,891 % in 2017. This is 15764 % less than in the previous year.

$1.99

Buy Net Debt Growth data for Pfizer Czech Republic.

$19.99

Buy all data for Pfizer Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic % ... ... ... ... ...           ... ... ... -17,482 83.3    
Bayer Czech Republic % ... ... ...               -71.1 -78.0 -272 13.5 595    
GlaxoSmithKline Czech Republic % ... ... ...               -18.8 76.2 33.3 -100 266,920    
Merck Czech Republic % ... ...                 13.5 -7.53 18.5 -86.2 -113    
Novartis Czech Republic %                     141 -75.5 -109 -2,141 -102    
Pfizer Czech Republic % ... ...                 -703 -113 -72.3 1,069 -98.5    
Roche Czech Republic % ... ... ...               -100 -40,192 88.9 90.0 21.9   ...
Sanofi-Aventis Czech Republic % ... ... ... ...             -4.00 14.4 -34.2 -46.3 -14.4    
Servier Czech Republic % ... ... ... ... ... ... ... ... ... ... ... ... 41.6 -14.0 -44.7    
Walmark % ... ... ...               -41.2 340 -22.8 -12.0 166